The Significance of Discs Large Homolog 2 Expression in Hepatocellular Carcinoma: A Laboratory Study
Jia-Wei Gu,Run-Qi Hong,Yi Zhang,Geng-Ming Niu,Zhi-Qing Hu,Xiao-Tian Zhang,Zhi-Peng Cao,Xi LI,Chong-Wei Ke
DOI: https://doi.org/10.23812/j.biol.regul.homeost.agents.20223605.132
2022-01-01
Journal of biological regulators and homeostatic agents
Abstract:Background: Hepatocellular carcinoma (HCC) is an aggressive tumor. The discs large homolog 2 (DLG2) is expressed in some malignancies, and it may be related to tumor progression. However, its role in HCC has not been explored. The aim of this study was to explore the prognostic value and role of DLG2 in HCC.Methods: The data of mRNA (messenger ribonucleic acid) expression from Gene Expression Omnibus (GEO), International Cancer Genome Consortium (ICGC) and The Cancer Genome Atlas (TCGA) databases were used to evaluate DLG2 expression in HCC tissues. The DLG2 protein level was checked for using immunohistochemistry analysis of a tissue microarray. The uni-variate and multivariate Cox regression analyses and the Kaplan-Meier analysis were used to evaluated the correlation between DLG2 expression and overall survival (OS). Gene set enrichment analysis (GSEA) was performed to research potential pathway that DLG2 participates in. DLG2 overexpression and knockdown cells were constructed using HCCLM3 cell line transfected with DLG2 overexpression vector and HepG2 transfected with shDLG2 (short hairpin RNA targeting at DLG2), respectively.Results: DLG2 was significantly downregulated in HCC tissues. DLG2 expression was significantly associated with the pT (pri-mary tumour) stage, tumor size, histological grade, and vessel invasion. More importantly, low DLG2 expression was significantly related to poor prognosis in advanced pStages (pathological stages), grade 3 HCC, alcoholic, and HBV (hepatitis B virus)-positive HCC patients. The MYC targets V2 (alias TCRGV9, T cell receptor gamma variable 9), E2F targets, and G2M (gap 2 phase and mitosis phase) checkpoint gene sets were differentially enriched in low DLG2 expression phenotype. DLG2 significantly correlated with MCM2 (minichromosome maintenance complex component 2), MCM5 (minichromosome maintenance complex component 5), MCM6 (minichromosome maintenance complex component 6), KPNA2 (karyopherin subunit alpha 2), CDK4 (cyclin-dependent kinase 4), H2AFZ (H2A histone family member Z), MAD2L1 (mitotic arrest deficient 2 like 1) and CDC20 (cell division cycle 20) in LIHC (liver hepatocellular carcinoma) patients. DLG2 silence and overexpression promoted and suppressed HCC proliferation, respectively.Conclusions: DLG2 might function as a biomarker of diagnosis and prognosis in HCC, and suppressed HCC cells proliferation.